Navigation path


Establishment, Strategy and Initial activities of the TuBerculosis Vaccine Initiative: Coordination of European efforts with global research initiatives
Framework programme:
Contract/Grant agreement number:
EC contribution:
430,000 €
24 months
Funding scheme:
Support Action
Starting date:
Project Web site:

Keywords: Tuberculosis, coordination, advocacy, TB-vaccine development, project management


There are currently several European initiatives aimed at an improved tuberculosis (TB) vaccine (the TBVAC and MUVAPRED projects supported by the Sixth Framework Programme (FP6), the European and Developing Countries Clinical Trials Partnership (EDCTP) and a number of global counterparts (the Bill & Melinda Gates Foundation (BMGF), the Grand Challenges in Global Health (GCGH) programme, the AERAS Global TB Vaccine Foundation, Stop TB, and some national programmes such as the Norwegian programme for Global Health and Vaccination Research (GLOBVAC). Although these programmes are striving to develop new and more effective vaccines against TB and involve many of the same stakeholders and participants, they all operate in parallel, and with their own focus. As a result, these efforts are being carried out without any coordinated overall strategy that could ensure a more effective use of current resources.

Lack of coordination also means that sharing of information is hampered, resulting in projects not necessarily using the latest data. There is also inevitably duplication of effort. To improve the level of coordination of these efforts, and to enable mobilisation of other required resources to support these activities, this project proposes to establish a new legal entity designated as Tuberculosis Vaccine Initiative (TBVI). Although it has been estimated that ultimate global control of TB (including developing improved vaccines) will require a total of more than EUR 30 billion, less than half of this is available 1. Increasing support is therefore imperative.

[+] Read More